Posters (60)

April, 2025

Analytical validation of ANGLE’s combined IF and FISH assay for assessment of HER2 in circulating tumor cells

ANGLE Europe Limited, Guildford, UK, published at AACR Annual Meeting 2025

January 2025

DDRi Summit 2025: Monitoring of DNA Damage Response Biomarkers using Circulating Tumour Cells captured with ANGLE’s Parsortix® instrument from Ovarian, Prostate, and Breast cancer patients

ANGLE Europe Limited, Guildford, UK, published at the 8th Annual DDR Inhibitors Summit 2025

December 2024

SABCS: A novel, semi-automated Pipeline for HER2 Quantification on CTCs in breast cancer patients. Is cytopathology of peripheral blood a new diagnostic option?

AACR LBx 24 – Development of a scoring system to classify HER2 protein expression in Circulating Tumour Cells through immunofluorescence following isolation using Parsortix® instruments

ANGLE Europe Limited, Guildford, UK, Published at the AACR LBx Conference 2024

AACR LBx 24 – Investigating PD-L1 status in Circulating Tumour Cells isolated from the blood samples of lung cancer patients

EACR LBx 24 – Enhancing Multiplexing Capabilities in Digital PCR for Circulating Tumour Cell Analysis Using Amplitude-Based Methodology

ANGLE Europe Limited, Guildford, UK, Published at the EACR LBx Conference 2024